SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-003954
Filing Date
2023-01-17
Accepted
2023-01-17 06:05:55
Documents
2
Group Members
BIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS EQUITY PARTNERS SOF I, LPBIOS SPECIAL OPPORTUNITY FUND II, LPBIOS SPECIAL OPPORTUNITY FUND, LPJOSEPH O'DONNELLKLEINHEINZ FAMILY FOUNDATION FOR THE ARTS & EDUCATIONPRECISE BIOS SPECIAL OPPORTUNITIES LLCR

Document Format Files

Seq Description Document Type Size
1 SC 13G tm233454d1_sc13g.htm SC 13G 218072
2 EXHIBIT 99.1 tm233454d1_ex99-1.htm EX-99.1 15856
  Complete submission text file 0001104659-23-003954.txt   235988
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Subject) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49893 | Film No.: 23530080
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address
Fletcher Aaron G.L. (Filed by) CIK: 0001789490 (see all company filings)

Type: SC 13G